Zobrazeno 1 - 6
of 6
pro vyhledávání: '"C R Albrightson-Winslow"'
Publikováno v:
Transplantation proceedings. 23(1 Pt 1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::73692feda73da4bae22ab286397ac5be
https://pubmed.ncbi.nlm.nih.gov/1990512
https://pubmed.ncbi.nlm.nih.gov/1990512
Autor:
C R, Albrightson-Winslow, B, Brickson, D P, Brooks, W M, Bryan, N, Caldwell, L B, Kinter, M L, Moore, P, Nambi, F L, Stassen, W F, Huffman
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 256(1)
A series of vasopressin analogs with various amino acid tail modifications were tested for antidiuretic agonist and antagonist (water diuretic) activity in the water-loaded indomethacin-treated and hydropenic dogs, respectively. Changing the carboxy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::28fa83debf5a637083e5ab8bed793f7f
https://pubmed.ncbi.nlm.nih.gov/1988664
https://pubmed.ncbi.nlm.nih.gov/1988664
Autor:
C R, Albrightson-Winslow, B, Brickson, A, King, D, Olivera, B, Short, C, Saunders, A M, Badger
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 255(1)
MRL/Mp-lpr/lpr (MRL/lpr) mice were studied from 6 to 19 weeks of age. Proteinuria began to increase at 15 weeks, and continued to increase until the animals were sacrificed at 19 weeks. This proteinuria was associated with lymphadenopathy and splenom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7cba7820d9b06093efc5dfc79557b113
https://pubmed.ncbi.nlm.nih.gov/2145424
https://pubmed.ncbi.nlm.nih.gov/2145424
Autor:
Kenneth A. Newlander, C R Albrightson-Winslow, Nancy Caldwell, L. B. Kinter, Drake S. Eggleston, Michael L. Moore, G. Dytko, Heidi G. Bryan, Bridget Brickson, William F. Huffman
Publikováno v:
Journal of Medicinal Chemistry. 32:880-884
[1-(beta,beta-Pentamethylene-beta-mercaptopropionic acid),2-(O-ethyl)-D- tyrosine,4-valine,9-desglycine]arginine-vasopressin (SK&F 101926, 1), a potent in vivo and in vitro vasopressin V2 receptor antagonist, was recently tested in human volunteers a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00421b7b5c1f996883c9fdea26d7d6f4
https://doi.org/10.1021/jm00124a025
https://doi.org/10.1021/jm00124a025
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 249(2)
The vasopressin (AVP) antagonist, SKF 101926 (beta-mercapto-beta beta-cyclopentamethylene propionic acid1, D-Tyr(Et)2, Phe3, Val4, Asn5, Cys6, Pro7, Arg8-NH2), is an antidiuretic antagonist in rats and squirrel monkeys in vivo. In rat, dog, pig, squi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::43f7549bbd780cf06e0e61e75243b4e8
https://pubmed.ncbi.nlm.nih.gov/2524585
https://pubmed.ncbi.nlm.nih.gov/2524585
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 245(1)
The vasopressin analog desGly(CH2)5D-Tyr(Et)VAVP (SKF 101926) is a potent antagonist of the antidiuretic action of vasopressin in rats, dogs, and squirrel monkeys, demonstrating minimal agonist activity in these species. In humans, however, SKF 10192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::307b654a493c80768902cfc65e182884
https://pubmed.ncbi.nlm.nih.gov/3361442
https://pubmed.ncbi.nlm.nih.gov/3361442